IN8bio, Inc. (INAB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IN8bio, Inc. on March 5, 2025, covering events occurring on March 4, 2025. The Company is a Delaware corporation with its principal executive offices in New York, New York, and its common stock trades on The Nasdaq Stock Market LLC under the symbol "INAB".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. On March 4, 2025, Travis Whitfill notified the Board of Directors of his resignation from the Board and its committees. The resignation is effective as of May 9, 2025. The Company stated that Mr. Whitfill's resignation is not due to any disagreement with the Company on any matter relating to its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, or specific risks beyond the standard disclosure of the director's departure. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- Travis Whitfill is resigning from the Board of Directors and all committees.
- The effective date of the resignation is May 9, 2025.
- The resignation is not attributed to any disagreement with the Company.
- The report was signed by Patrick McCall, Chief Financial Officer and Secretary.